{"brief_title": "Adult Primary Insomnia Polysomnographic Study (0928-004)(COMPLETED)", "brief_summary": "The purpose of the study is to test the safety and effectiveness of the Investigational Drug on insomnia.", "condition": ["Primary Insomnia"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["gaboxadol", "Comparator: placebo (unspecified)"], "description": ["Duration of Treatment - 6 weeks", "Duration of Treatment - 6 weeks"], "other_name": ["MK0928"], "criteria": "Inclusion Criteria: - Adult patients with a diagnosis of primary insomnia and in good physical and mental health Exclusion Criteria: - Adult patients with other medical , neurological and sleep disorders", "gender": "All", "minimum_age": "18 Years", "maximum_age": "64 Years", "healthy_volunteers": "No", "mesh_term": ["Sleep Initiation and Maintenance Disorders", "Gaboxadol"], "id": "NCT00094627"}